Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Sciformix Executives Drive Agenda on Achieving Drug Safety Excellence at World Drug Safety Congress

Published: Thursday, March 28, 2013
Last Updated: Thursday, March 28, 2013
Bookmark and Share
5th Annual World Drug Safety Congress to be held from April 24 - 25, 2013 at Boston, USA.

Sciformix Corporation has announced its premium sponsorship of the 5th annual World Drug Safety Congress, taking place from April 24 - 25, 2013 at the Revere Hotel Boston Common, Boston, USA.

The World Drug Safety Congress addresses strategic and crucial issues in the development and execution of drug safety programs.

Senior executives of Sciformix, will be chairing the opening session and setting the stage on how organizations can stay on top of international regulatory requirements and streamline their drug safety programs.

Sciformix, premium sponsors of the event for the third year in a row, continues its success in its global delivery of services and solutions in Safety and Risk Management.

Their scientific and safety experts work closely with the top global pharmaceutical and biopharmaceutical, generics, consumer product and medical devices organizations to support their safety needs throughout the entire product lifecycle.

With substantial growth in business year on year, Sciformix is taking its position as a leader in drug safety services.

The World Drug Safety Congress aims to present innovative solutions to the key safety challenges facing both pharmaceutical industry and pharmacovigilance professionals worldwide.

It brings together senior personnel from a range of global pharmaceutical companies, regulatory agencies and academic institutions to share their expertise in the drug safety arena.

The conference provides an excellent opportunity for attendees to discuss diverse issues related to drug safety with specialists and practitioners.

At the conference, Sciformix will be demonstrating its expertise by engaging with the speakers and delegates, sharing their knowledge of key developments in the global drug safety market, and demonstrating solutions that provide competitive advantage to participating companies.

Manish Soman, President and CEO comments “We are delighted to be a part of the World Drug Safety Congress. Our support of the event is part of our ongoing investment in the field of drug safety. We want to share the knowledge we have gained while working with clients over the years, which has been incorporated into our innovative methodology and approaches to the problems of drug safety and risk management”.

To help drug safety professionals achieve excellence, world renowned expert Sidney Kahn, Senior Principal Pharmacovigilance Practice at Sciformix, will be addressing the audience with his keynote presentation on “The challenges in achieving excellence in the rapidly evolving global drug safety environment”.

On the second day of the conference, Chitra Lele, Chief Scientific Officer and co-founder at Sciformix will host an in-depth presentation and panellist discussion on “Taking the noise out of signal detection”.

Experts including Ram Tiwari, Ph.D., Associate Director, Office of Biostatistics, Center for Drug Evaluation & Research, US FDA and Michael Sprafka, Executive Director of Observation Research, Head of Pharmacovigilance-Epidemiology, Amgen, will provide practical solutions to the problems of inadequacies of available quantitative measures and indicate possible enhancements of the method during an informative and thought provoking presentation and panel discussion.

Sciformix partners with their clients through the entire drug development cycle, to provide a full range of services from study design to post marketing surveillance and commercialization support.

Areas of specialization include Safety and Risk Management, Clinical Research & Post Approval Services, Medical Affairs, Scientific Writing and Regulatory Affairs.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos